Neisseria meningitidis: Clinical aspects

Journal of Infection

Volumn 34, Issue 1, 1997, Pages 15-19

  Cartwright, K A V ^a   Ala'Aldeen, D A A ^b  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; PENICILLIN G;

BACTERIAL MENINGITIS; CLINICAL FEATURE; HUMAN; MENINGOCOCCOSIS; MORBIDITY; MORTALITY; NEISSERIA MENINGITIDIS; SHORT SURVEY;

EID: 0031046374     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(97)80004-7     Document Type: Review

References (32)

1. Cartwright K. Meningococcal carriage and disease. In: Cartwright K, ed. Meningococcal disease. Chichester: John Wiley and Sons, 1995; 114-146.
2. Griffiss JM. Mechanisms of host immunity. In: Cartwright K, ed. Meningococcal disease. Chichester: John Wiley and Sons, 1995; 35-70.
3. Rake G. Studies of meningococcus infection. VI. The carrier problem. J Exp Med 1934; 59: 553-576.
4. Carpenter RR. The clinical spectrum of bacterial meningitis. Am J Med 1962; 33: 262-275.
5. deMorais JS, Munford RS, Risi JB, Antezana E, Feldman RA. Epidemic disease due to serogroup C Neisseria meningitidis in Sao Paulo, Brazil. J Infect Dis 1974; 129: 568-571.
6. Jones DM, Kaczmarski EB. Meningococcal infections in England and Wales: 1994. Commun Dis Rep 1995; 5: R125-R130.
7. Stiehm ER, Damrosch DS. Factors in the prognosis of meningococcal infection. J Pediatr 1966; 68: 457-467.
8. Niklasson P-M, Lundbergh P, Strandell T. Prognostic factors in meningococcal disease. Scand J Infect Dis 1971; 3: 17-25.
9. Sinclair JF, Skeoch CH, Hallworth D. Prognosis of meningococcal septicaemia. Lancet 1987; ii: 38.
10. Department of Health. Preparation of heavy suspensions of Neisseria meningitidis on the open bench: risk of laboratory-acquired infection. Health Circular HC(Hazard) (93)1. London: Medical Devices Directorate, 1993.
11. Mellor DA. The place of computed tomography and lumbar puncture in suspected bacterial meningitis. Arch Dis Child 1992; 67: 1417-1419.
12. Cartwright K, Reilly S, White D, Stuart J. Early treatment with parenteral penicillin in meningococcal disease. Br Med J 1992; 305: 143-147.
13. van Deuren M, van Dijke BJ, Koopman RJJ et al. Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. Br Med J 1993; 306: 1229-1230.
14. Kaczmarski EB, Cartwright KAV. Control of meningococcal disease: guidance for microbiologists. Commun Dis Rep 1995; 5: R196-R198.
15. Ni H, Knight AI, Cartwright K, Palmer WH, McFadden J. Polymerase chain reaction for diagnosis of meningococcal meningitis. Lancet 1992; 340: 1432-1434.
16. Newcombe J, Cartwright K, Palmer WH, McFadden J. Polymerase chain reaction of peripheral blood for the diagnosis of meningococcal disease. J Clin Microbiol 1996; 34: 1637-1640.
17. Algren JT, Lal S, Cutliff SA, Richman BJ. Predictors of outcome in acute meningococcal infection in children. Crit Care Med 1993; 21: 447-452.
18. Cartwright K, Strang J, Gossain S, Begg N. Early treatment of meningococcal disease. Br Med J 1992; 305: 774.
19. Meningitis Working Party of the British Paediatric Immunology and Infectious Diseases Group. Should we use dexamethasone in meningitis? Arch Dis Child 1992; 67: 1398-1401.
20. Zhang QY, Jones DM, Saez-Nieto JA, Perez-Trallero E, Spratt BG. Genetic diversity of penicillin-binding 2 genes of penicillin-resistant strains of Neisseria meningitidis revealed by fingerprinting of amplified DNA. Antimicrob Agents Chemother 1990; 34: 1523-1528.
21. Saez-Nieto JA, Lujan R, Berron S et al. Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis: 5-year history (1985-1989). Clin Infect Dis 1992; 14: 394-402.
22. Botha P. Penicillin-resistant Neisseria meningitidis in Southern Africa. Lancet 1988; i: 54.
23. Fontanals D, Pineda V, Pons I, Rojo JC. Penicillin-resistant beta-lactamase producing Neisseria meningitidis in Spain. Eur J Clin Microbiol Infect Dis 1989; 8: 90-91.
24. Peltola H, Anttila M, Renkonen O-V. Randomised comparison of chloramphenicol, ampicillin, cefotaxime and ceftriaxone for childhood bacterial meningitis. Lancet 1989; i: 1281-1287.
25. Radetsky M. Duration of treatment in bacterial meningitis: a historical inquiry. Pediatr Infect Dis 1990; 9: 2-9.
26. McCracken GH, Nelson JD, Kaplan SL, Overturf GD, Rodriguez WJ, Steele RW. Consensus report: antimicrobial therapy for bacterial meningitis in infants and children. Pediatr Infect Dis J 1987; 6: 501-505.
27. Brandtzaeg P, Kierulf P, Gaustad P et al. Plasma endotoxin as predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989; 159: 195-204.
28. Feigin RD, McCracken GH, Klein JO. Diagnosis and management of meningitis. Pediatr Infect Dis J 1992; 11: 785-814.
29. Schaad UB, Lips U, Gnehm HE, Blumberg A, Heinzer I, Wedgwood. Dexamethasone therapy for bacterial meningitis in children. Lancet 1993; 342: 457-461.
30. Nadel S, Levin M, Habibi P. Treatment of meningococcal disease in childhood. In: Cartwright K, ed. Meningococcal disease. Chichester: John Wiley and Sons, 1995; 207-243.
31. PHLS Meningococcal Infections Working Group and Public Health Medicine Environmental Group. Control of meningococcal disease: guidance for consultants in communicable disease control. Commun Dis Rep 1995; 5: R189-R195.
32. Stuart JM, Cartwright KAV, Robinson PM, Noah ND. Does eradication of meningococcal carriage in household contacts prevent secondary cases of meningococcal disease? Br Med J 1989; 298: 569-570.